Patent details

Basic Information

Publication number:

EP2379498

PCT Application Number:

PCT/US/2009/068346

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097934236

PCT Publication Number:

WO/2010/071794

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

POLYMORPHIC FORM OF 1-(4-{1-Ö(E)-4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINOÜ-ETHYL}-2-ETHYL-BENZYL) -AZETIDINE-3-CARBOXYLIC ACID

French Title of Invention:

FORME POLYMORPHE DE L' ACIDE 1-(4-{1-Ö(E)-4-CYCLOHEXYL-3-TRIFLUOROMÉTHYL-BENZYLOXYIMINOÜ-ÉTHYL}-2-ÉTHYL-BENZYL)-AZÉTIDINE-3-CARBOXYLIQUE

German Title of Invention:

POLYMORPHE FORM VON 1-(4-{L-Ö(E)-4-CYCLOHEXYL-3- TRIFLUORMETHYLBENZYLOXYIMINOÜETHYL}-2-ETHYLBENZYL)AZETIDIN-3-CARBONSÄURE

SPC Number:

Dates

Filing date:

17/12/2009

Grant date:

21/01/2015

EP Publication Date:

21/01/2015

PCT Publication Date:

24/06/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/10/2011

EP B1 Publication Date:

21/01/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/12/2015

Expiration date:

17/12/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/12/2009

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

LIU Yugang

Address:

United States (US)

2

Name:

PAPOUTSAKIS Dimitris

Address:

United States (US)

3

Name:

RODDY Elizabeth

Address:

United States (US)

Priority

Priority Number:

203052 P

Priority Date:

04/05/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 205/04;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages